Ads
related to: rooibos tea and breast cancer patientssmartholidayshopping.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
Essiac is a herbal tea promoted as an alternative treatment for cancer and other illnesses. [1] There is no evidence it is beneficial to health. In a number of studies Essiac either showed no action against cancer cells, [ 2 ] [ 3 ] [ 4 ] or actually increased the rate of cancer growth.
Diagnosis dates are listed where the information is known. Breast cancer is the second most common cancer in women after skin cancer. According to the United States National Cancer Institute, the rate of new cases of female breast cancer was 129.1 per 100,000 women per year. The death rate was 19.9 per 100,000 women per year.
The nature of that knowledge was not documented. Given the available data, the origin of rooibos tea can be viewed in the context of the global expansion of tea trade and the colonial habit of drinking Chinese and later Ceylon tea. In that case, the rooibos infusion or decoction served as a local replacement for the expensive Asian product. [20]
Benjamin Ginsberg created and launched the oldest existing brand of packed rooibos tea, Eleven O’Clock. After Benjamin's death, his son Charles took over the business, introducing sophisticated machinery to cut the unusual leaves and building large “courts” on his farms in which to dry and cure the tea under the hot Cederberg sun.
Anti-cancer psychotherapy – a technique [131] claiming that a "cancer personality" caused cancer, which could be cured through talk therapy (e.g. that of the Simonton Cancer Center, [132] Bernie Siegel's "Exceptional Cancer Patients" (ECaP) or Deepak Chopra). Evidence is lacking that cancer cures sold or promoted by Deepak Chopra have any value.
The topic of breast cancer can be used to highlight the differences in treatment practices between Western countries and China. This is despite the fact that the incidence of breast cancer in China was approximately 215,600 patients in 2011, which compares closely to the incidence in the United States of America.